ONCT - Oncternal Therapeutics Inc. (ONCT) CEO James Breitmeyer on Q3 2019 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc. (ONCT)
Q3 2019 Earnings Conference Call
November 7, 2019 5:00 P.M. ET
Company Participants
Richard Vincent - Chief Financial Officer
James Breitmeyer - President and Chief Executive Officer
Frank Hsu - Chief Medical Officer
Conference Call Participants
Hartaj Singh - Oppenheimer & Company
Kumar Raja - Brookline Capital Markets
Presentation
Operator
Greetings and welcome to the Oncternal Therapeutics Third Quarter Earnings and Business Update Call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the follow the formal presentation. [Operator Instructions] As